HEADER VIRUS 11-JAN-21 7BH9 TITLE SARS-COV-2 RBD-62 IN COMPLEX WITH ACE2 PEPTIDASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANGIOTENSIN-CONVERTING ENZYME HOMOLOG,ACEH,ANGIOTENSIN- COMPND 5 CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE,ACE-RELATED COMPND 6 CARBOXYPEPTIDASE,METALLOPROTEASE MPROT15; COMPND 7 EC: 3.4.17.23,3.4.17.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: SARS-COV-2 RECEPTOR BINDING DOMAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 11 2; SOURCE 12 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 13 ORGANISM_TAXID: 2697049; SOURCE 14 GENE: S, 2; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS IN VITRO EVOLUTION, COMPLEX, RECEPTOR BINDING DOMAIN, VIRUS EXPDTA ELECTRON MICROSCOPY AUTHOR N.ELAD,O.DYM,J.ZAHRADNIK,G.SCHREIBER REVDAT 4 22-SEP-21 7BH9 1 JRNL REVDAT 3 01-SEP-21 7BH9 1 JRNL REVDAT 2 10-MAR-21 7BH9 1 COMPND SOURCE DBREF SEQADV REVDAT 1 17-FEB-21 7BH9 0 JRNL AUTH J.ZAHRADNIK,S.MARCIANO,M.SHEMESH,E.ZOLER,D.HARARI, JRNL AUTH 2 J.CHIARAVALLI,B.MEYER,Y.RUDICH,C.LI,I.MARTON,O.DYM,N.ELAD, JRNL AUTH 3 M.G.LEWIS,H.ANDERSEN,M.GAGNE,R.A.SEDER,D.C.DOUEK,G.SCHREIBER JRNL TITL SARS-COV-2 VARIANT PREDICTION AND ANTIVIRAL DRUG DESIGN ARE JRNL TITL 2 ENABLED BY RBD IN VITRO EVOLUTION. JRNL REF NAT MICROBIOL V. 6 1188 2021 JRNL REFN ESSN 2058-5276 JRNL PMID 34400835 JRNL DOI 10.1038/S41564-021-00954-4 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : SERIALEM, CRYOSPARC, PHENIX, CRYOSPARC, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 6M0J REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.900 REMARK 3 NUMBER OF PARTICLES : 164636 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7BH9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1292113381. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 RBD-62 IN COMPLEX REMARK 245 WITH ACE2 PEPTIDASE DOMAIN; REMARK 245 ACE2 EXTRACELLULAR PEPTIDASE REMARK 245 DOMAIN; SARS-COV-2 RECEPTOR REMARK 245 BINDING DOMAIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 3.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 4470 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 7000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 165000 REMARK 245 CALIBRATED MAGNIFICATION : 94518 REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 17 REMARK 465 SER A 18 REMARK 465 ASN A 134 REMARK 465 PRO A 135 REMARK 465 ASP A 136 REMARK 465 ASN A 137 REMARK 465 PRO A 138 REMARK 465 GLN A 139 REMARK 465 GLU A 140 REMARK 465 ASN A 338 REMARK 465 VAL A 339 REMARK 465 ALA A 614 REMARK 465 ASP A 615 REMARK 465 GLY A 616 REMARK 465 GLY A 617 REMARK 465 SER A 618 REMARK 465 GLY A 619 REMARK 465 THR A 620 REMARK 465 HIS A 621 REMARK 465 HIS A 622 REMARK 465 HIS A 623 REMARK 465 HIS A 624 REMARK 465 HIS A 625 REMARK 465 HIS A 626 REMARK 465 THR E 333 REMARK 465 ASN E 334 REMARK 465 LEU E 335 REMARK 465 CYS E 336 REMARK 465 PRO E 337 REMARK 465 PHE E 338 REMARK 465 GLY E 339 REMARK 465 GLU E 340 REMARK 465 ARG E 357 REMARK 465 PHE E 358 REMARK 465 SER E 359 REMARK 465 ASN E 360 REMARK 465 CYS E 361 REMARK 465 VAL E 362 REMARK 465 ALA E 363 REMARK 465 ASP E 364 REMARK 465 TYR E 365 REMARK 465 SER E 366 REMARK 465 VAL E 367 REMARK 465 LEU E 368 REMARK 465 TYR E 369 REMARK 465 ASN E 370 REMARK 465 SER E 371 REMARK 465 GLY E 381 REMARK 465 VAL E 382 REMARK 465 SER E 383 REMARK 465 PRO E 384 REMARK 465 THR E 385 REMARK 465 LYS E 386 REMARK 465 LEU E 387 REMARK 465 ASN E 388 REMARK 465 ASP E 389 REMARK 465 LEU E 390 REMARK 465 CYS E 391 REMARK 465 PHE E 392 REMARK 465 THR E 393 REMARK 465 ASN E 394 REMARK 465 VAL E 395 REMARK 465 PHE E 515 REMARK 465 GLU E 516 REMARK 465 LEU E 517 REMARK 465 LEU E 518 REMARK 465 HIS E 519 REMARK 465 ALA E 520 REMARK 465 PRO E 521 REMARK 465 ALA E 522 REMARK 465 THR E 523 REMARK 465 VAL E 524 REMARK 465 CYS E 525 REMARK 465 GLY E 526 REMARK 465 PRO E 527 REMARK 465 LYS E 528 REMARK 465 HIS E 529 REMARK 465 HIS E 530 REMARK 465 HIS E 531 REMARK 465 HIS E 532 REMARK 465 HIS E 533 REMARK 465 HIS E 534 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 56 CG CD OE1 OE2 REMARK 470 ASP A 67 CG OD1 OD2 REMARK 470 LYS A 68 CE NZ REMARK 470 LYS A 74 CD CE NZ REMARK 470 GLU A 75 CD OE1 OE2 REMARK 470 GLN A 86 CD OE1 NE2 REMARK 470 GLU A 87 CG CD OE1 OE2 REMARK 470 GLN A 89 CD OE1 NE2 REMARK 470 GLN A 102 CG CD OE1 NE2 REMARK 470 GLU A 110 CG CD OE1 OE2 REMARK 470 LYS A 114 CD CE NZ REMARK 470 GLU A 150 CG CD OE1 OE2 REMARK 470 ASP A 213 CG OD1 OD2 REMARK 470 GLN A 287 CG CD OE1 NE2 REMARK 470 ASP A 299 CG OD1 OD2 REMARK 470 ARG A 306 CZ NH1 NH2 REMARK 470 ASP A 427 CG OD1 OD2 REMARK 470 GLN A 429 CG CD OE1 NE2 REMARK 470 GLU A 433 CG CD OE1 OE2 REMARK 470 LYS A 470 CE NZ REMARK 470 LYS A 475 CE NZ REMARK 470 GLU A 536 CG CD OE1 OE2 REMARK 470 LYS A 600 CG CD CE NZ REMARK 470 ASN A 601 CG OD1 ND2 REMARK 470 ASP A 609 CG OD1 OD2 REMARK 470 ASN E 343 CG OD1 ND2 REMARK 470 ARG E 346 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 356 CG CD CE NZ REMARK 470 LYS E 378 CG CD CE NZ REMARK 470 ASP E 427 CG OD1 OD2 REMARK 470 ASP E 428 CG OD1 OD2 REMARK 470 THR E 430 OG1 CG2 REMARK 470 LYS E 458 CE NZ REMARK 470 LYS E 462 CG CD CE NZ REMARK 470 GLU E 465 CG CD OE1 OE2 REMARK 470 GLU E 471 CG CD OE1 OE2 REMARK 470 ASN E 481 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 19 OE1 GLU A 23 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 81 0.33 -61.48 REMARK 500 ASN A 277 3.96 -65.34 REMARK 500 ALA A 301 60.35 60.60 REMARK 500 PRO A 336 43.97 -84.58 REMARK 500 TYR A 385 30.71 -94.20 REMARK 500 ASP A 471 7.18 -66.55 REMARK 500 ASP A 509 61.17 63.04 REMARK 500 VAL A 574 -62.60 -95.32 REMARK 500 SER E 438 28.97 -143.44 REMARK 500 THR E 500 52.10 -93.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 901 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 92.2 REMARK 620 3 GLU A 402 OE1 105.5 100.1 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-12187 RELATED DB: EMDB REMARK 900 SARS-COV-2 RBD-62 IN COMPLEX WITH ACE2 PEPTIDASE DOMAIN DBREF 7BH9 A 19 615 UNP Q9BYF1 ACE2_HUMAN 19 615 DBREF 7BH9 E 333 528 UNP P0DTC2 SPIKE_SARS2 333 528 SEQADV 7BH9 GLY A 17 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 SER A 18 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 GLY A 616 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 GLY A 617 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 SER A 618 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 GLY A 619 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 THR A 620 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 HIS A 621 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 HIS A 622 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 HIS A 623 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 HIS A 624 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 HIS A 625 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 HIS A 626 UNP Q9BYF1 EXPRESSION TAG SEQADV 7BH9 PHE E 358 UNP P0DTC2 ILE 358 ENGINEERED MUTATION SEQADV 7BH9 LYS E 445 UNP P0DTC2 VAL 445 ENGINEERED MUTATION SEQADV 7BH9 LYS E 460 UNP P0DTC2 ASN 460 ENGINEERED MUTATION SEQADV 7BH9 THR E 468 UNP P0DTC2 ILE 468 ENGINEERED MUTATION SEQADV 7BH9 MET E 470 UNP P0DTC2 THR 470 ENGINEERED MUTATION SEQADV 7BH9 ASN E 477 UNP P0DTC2 SER 477 ENGINEERED MUTATION SEQADV 7BH9 LYS E 484 UNP P0DTC2 GLU 484 ENGINEERED MUTATION SEQADV 7BH9 ARG E 498 UNP P0DTC2 GLN 498 ENGINEERED MUTATION SEQADV 7BH9 TYR E 501 UNP P0DTC2 ASN 501 ENGINEERED MUTATION SEQADV 7BH9 HIS E 529 UNP P0DTC2 EXPRESSION TAG SEQADV 7BH9 HIS E 530 UNP P0DTC2 EXPRESSION TAG SEQADV 7BH9 HIS E 531 UNP P0DTC2 EXPRESSION TAG SEQADV 7BH9 HIS E 532 UNP P0DTC2 EXPRESSION TAG SEQADV 7BH9 HIS E 533 UNP P0DTC2 EXPRESSION TAG SEQADV 7BH9 HIS E 534 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 610 GLY SER SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU SEQRES 2 A 610 ASP LYS PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SEQRES 3 A 610 SER SER LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR SEQRES 4 A 610 GLU GLU ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS SEQRES 5 A 610 TRP SER ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN SEQRES 6 A 610 MET TYR PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS SEQRES 7 A 610 LEU GLN LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL SEQRES 8 A 610 LEU SER GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU SEQRES 9 A 610 ASN THR MET SER THR ILE TYR SER THR GLY LYS VAL CYS SEQRES 10 A 610 ASN PRO ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO SEQRES 11 A 610 GLY LEU ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN SEQRES 12 A 610 GLU ARG LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL SEQRES 13 A 610 GLY LYS GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL SEQRES 14 A 610 LEU LYS ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP SEQRES 15 A 610 TYR GLY ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY SEQRES 16 A 610 VAL ASP GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU SEQRES 17 A 610 ASP VAL GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR SEQRES 18 A 610 GLU HIS LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN SEQRES 19 A 610 ALA TYR PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO SEQRES 20 A 610 ALA HIS LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR SEQRES 21 A 610 ASN LEU TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO SEQRES 22 A 610 ASN ILE ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP SEQRES 23 A 610 ASP ALA GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE SEQRES 24 A 610 VAL SER VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP SEQRES 25 A 610 GLU ASN SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS SEQRES 26 A 610 ALA VAL CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY SEQRES 27 A 610 ASP PHE ARG ILE LEU MET CYS THR LYS VAL THR MET ASP SEQRES 28 A 610 ASP PHE LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN SEQRES 29 A 610 TYR ASP MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG SEQRES 30 A 610 ASN GLY ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU SEQRES 31 A 610 ILE MET SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SEQRES 32 A 610 SER ILE GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN SEQRES 33 A 610 GLU THR GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR SEQRES 34 A 610 ILE VAL GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS SEQRES 35 A 610 TRP ARG TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP SEQRES 36 A 610 GLN TRP MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE SEQRES 37 A 610 VAL GLY VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR SEQRES 38 A 610 CYS ASP PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SEQRES 39 A 610 SER PHE ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE SEQRES 40 A 610 GLN PHE GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU SEQRES 41 A 610 GLY PRO LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU SEQRES 42 A 610 ALA GLY GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SEQRES 43 A 610 SER GLU PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY SEQRES 44 A 610 ALA LYS ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE SEQRES 45 A 610 GLU PRO LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SEQRES 46 A 610 SER PHE VAL GLY TRP SER THR ASP TRP SER PRO TYR ALA SEQRES 47 A 610 ASP GLY GLY SER GLY THR HIS HIS HIS HIS HIS HIS SEQRES 1 E 202 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 E 202 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG PHE SEQRES 3 E 202 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 E 202 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 E 202 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 E 202 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 E 202 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 E 202 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 E 202 ASN SER ASN ASN LEU ASP SER LYS LYS GLY GLY ASN TYR SEQRES 10 E 202 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER LYS LEU LYS SEQRES 11 E 202 PRO PHE GLU ARG ASP THR SER MET GLU ILE TYR GLN ALA SEQRES 12 E 202 GLY ASN THR PRO CYS ASN GLY VAL LYS GLY PHE ASN CYS SEQRES 13 E 202 TYR PHE PRO LEU GLN SER TYR GLY PHE ARG PRO THR TYR SEQRES 14 E 202 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 E 202 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 16 E 202 LYS HIS HIS HIS HIS HIS HIS HET ZN A 901 1 HET NAG A 902 14 HET NAG A 903 14 HET NAG A 904 14 HETNAM ZN ZINC ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 ZN ZN 2+ FORMUL 4 NAG 3(C8 H15 N O6) HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 GLU A 57 GLN A 81 1 25 HELIX 3 AA3 PRO A 84 ILE A 88 5 5 HELIX 4 AA4 ASN A 90 GLN A 101 1 12 HELIX 5 AA5 ASN A 103 LEU A 108 5 6 HELIX 6 AA6 GLU A 110 THR A 129 1 20 HELIX 7 AA7 LEU A 148 ASN A 154 1 7 HELIX 8 AA8 ASP A 157 VAL A 172 1 16 HELIX 9 AA9 VAL A 172 ALA A 193 1 22 HELIX 10 AB1 ASP A 198 GLY A 205 1 8 HELIX 11 AB2 ASP A 206 GLU A 208 5 3 HELIX 12 AB3 GLN A 221 TYR A 252 1 32 HELIX 13 AB4 PRO A 253 ILE A 256 5 4 HELIX 14 AB5 HIS A 265 LEU A 267 5 3 HELIX 15 AB6 TRP A 275 THR A 282 5 8 HELIX 16 AB7 VAL A 293 ASP A 299 1 7 HELIX 17 AB8 ASP A 303 VAL A 318 1 16 HELIX 18 AB9 THR A 324 SER A 331 1 8 HELIX 19 AC1 ASP A 367 TYR A 385 1 19 HELIX 20 AC2 PRO A 389 ARG A 393 5 5 HELIX 21 AC3 PHE A 400 ALA A 413 1 14 HELIX 22 AC4 THR A 414 ILE A 421 1 8 HELIX 23 AC5 GLU A 433 VAL A 447 1 15 HELIX 24 AC6 THR A 449 GLY A 466 1 18 HELIX 25 AC7 PRO A 469 ASP A 471 5 3 HELIX 26 AC8 GLN A 472 LYS A 481 1 10 HELIX 27 AC9 CYS A 498 SER A 502 5 5 HELIX 28 AD1 LEU A 503 ASN A 508 1 6 HELIX 29 AD2 ILE A 513 ALA A 533 1 21 HELIX 30 AD3 PRO A 538 CYS A 542 5 5 HELIX 31 AD4 THR A 548 ARG A 559 1 12 HELIX 32 AD5 PRO A 565 VAL A 574 1 10 HELIX 33 AD6 VAL A 581 PHE A 588 1 8 HELIX 34 AD7 PHE A 588 ASN A 599 1 12 HELIX 35 AD8 LYS A 600 SER A 602 5 3 HELIX 36 AD9 ARG E 403 ILE E 410 5 8 HELIX 37 AE1 LYS E 417 ASN E 422 1 6 SHEET 1 AA1 2 LYS A 131 VAL A 132 0 SHEET 2 AA1 2 LEU A 142 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 ASP A 350 0 SHEET 2 AA3 2 PHE A 356 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 AA4 4 THR E 376 CYS E 379 0 SHEET 2 AA4 4 CYS E 432 ASN E 437 -1 O ALA E 435 N THR E 376 SHEET 3 AA4 4 TYR E 508 LEU E 513 -1 O ARG E 509 N TRP E 436 SHEET 4 AA4 4 ALA E 397 ILE E 402 -1 N PHE E 400 O VAL E 510 SHEET 1 AA5 2 ASN E 448 ARG E 454 0 SHEET 2 AA5 2 LEU E 492 PHE E 497 -1 O GLN E 493 N TYR E 453 SHEET 1 AA6 2 TYR E 473 GLN E 474 0 SHEET 2 AA6 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SSBOND 1 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 2 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 3 CYS E 480 CYS E 488 1555 1555 1.99 LINK ND2 ASN A 53 C1 NAG A 904 1555 1555 1.44 LINK ND2 ASN A 90 C1 NAG A 903 1555 1555 1.43 LINK ND2 ASN A 546 C1 NAG A 902 1555 1555 1.43 LINK NE2 HIS A 374 ZN ZN A 901 1555 1555 2.34 LINK NE2 HIS A 378 ZN ZN A 901 1555 1555 2.06 LINK OE1 GLU A 402 ZN ZN A 901 1555 1555 2.02 CISPEP 1 GLU A 145 PRO A 146 0 -1.65 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000